COVID-19: Current coronavirus vaccines unlikely to protect against new variants in future, SAGE warnsRead Now
The government's scientific advisers say COVID may continue to evolve for years to come and "eradication is extremely unlikely".
Current COVID-19 vaccines are unlikely to protect against new variants of the virus in the future, the government's scientific advisers have warned.
In a paper published on Friday, the Scientific Advisory Group for Emergencies (SAGE) said coronavirus may continue to evolve for years to come and that "eradication is extremely unlikely".
The experts warn that eventually it is likely "current vaccines will fail to protect against transmission, infection, or even against disease caused by newer variants".
Read the full article here.
Refana Inc., is United States registered private corporation dedicated to finding practical and innovative solutions to the world's medical problems. By utilizing a highly collaborative open source system of research and development Refana has been able to attract world leaders in their respective scientific and medical fields to work on these problems. Through this model Refana hopes to greatly accelerate the vaccine development process for Covid-19 and help protect not only the health of the world, but also the economies and stability of nations at risk.